Table 5 Relation of treatment of the studied patients with PET-CT findings in follow up patients with colorectal carcinoma after adjuvant chemotherapy
From: FDG PET/CT in follow UP patients with colorectal carcinoma after adjuvant chemotherapy
| Â | Chemo/radio | Test value | P-value | Sig. |
|---|---|---|---|---|
Chemo | Combined | |||
No. = 24 | No. = 6 | |||
Recurrence | Positive | 0.139* | 0.709 | NS |
| Â | Â | 14 (58.3%) | 4 (66.7%) | Â |
Local spread | Positive | 0.139* | 0.709 | NS |
| Â | Â | 14 (58.3%) | 4 (66.7%) | Â |
Metastases | Positive | 1.663* | 0.197 | NS |
| Â | Â | 15 (62.5%) | 2 (33.3%) | Â |
Hepatic deposits | Positive | 0.139* | 0.709 | NS |
| Â | Â | 10 (41.7%) | 2 (33.3%) | Â |
Pulmonary deposits | Positive | 0.384* | 0.536 | NS |
| Â | Â | 7 (29.2%) | 1 (16.7%) | Â |
Local LNs | Positive | 0.313* | 0.576 | NS |
| Â | Â | 15 (62.5%) | 3 (50.0%) | Â |
Distant LNs | Positive | 1.292* | 0.256 | NS |
| Â | Â | 10 (41.7%) | 1 (16.7%) | Â |
Bone deposits | Positive | 0.052* | 0.819 | NS |
| Â | Â | 5 (20.8%) | 1 (16.7%) | Â |
Peritoneal deposits | Positive | 1.154* | 0.283 | NS |
| Â | Â | 4 (16.7%) | 0 (0.0%) | Â |
False + ve | Positive | 4.537* | 0.033 | S |
| Â | Â | 1 (4.2%) | 2 (33.3%) | Â |
False –ve | Positive | 0.833* | 0.361 | NS |
| Â | Â | 3 (12.5%) | 0 (0.0%) | Â |